OSR Health OSRH
NASDAQ OSRH
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

OSR Health (OSRH) Non Operating Interest Expenses (2024 - 2026)

OSR Health's (OSRH) quarterly Non Operating Interest Expenses came in at $199024.0 in Q2 2026, down 3.83% year-over-year from $206960.0 in Q2 2025, and down 18.19% quarter-over-quarter from $243289.2 in Q1 2026.

Analysis

OSR Health (OSRH) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends

OSR Health has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $199024.0 for Q2 2026.

  • In Q2 2026, Non Operating Interest Expenses fell 3.83% year-over-year to $199024.0; the TTM figure through Jun 2026 stood at $6.2 million (down 29.56% YoY), while the FY2025 annual figure was $14.4 million, up 5257.59% from the prior year.
  • Non Operating Interest Expenses came in at $199024.0 for Q2 2026 at OSR Health, down from $243289.2 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $8.5 million in Q1 2025 to a low of $9114.0 in Q3 2024.
  • Average Non Operating Interest Expenses over 3 years is $1.5 million, with a median of $202992.0 recorded in 2025.
  • Year-over-year, Non Operating Interest Expenses soared 11758.2% in 2025 and slumped 97.13% in 2026.
  • Over 3 years, Non Operating Interest Expenses stood at $163566.0 in 2024, then jumped by 3029.89% to $5.1 million in 2025, then slumped by 96.11% to $199024.0 in 2026.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $199024.0 in Q2 2026, $243289.2 in Q1 2026, and $5.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 82.05 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 OSR Health 6.59 Mn 4.94 Mn 86,605.00 199,024.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 199,024.00
Mar 31, 2026 243,289.19
Dec 31, 2025 5.12 Mn
Sep 30, 2025 685,218.00
Jun 30, 2025 206,960.00
Mar 31, 2025 8.49 Mn
Dec 31, 2024 163,566.00
Sep 30, 2024 9,114.00
Jun 30, 2024 69,358.00
Mar 31, 2024 71,591.00